As COVID-19 cases continue to rise across the United States, scientists are monitoring the spread of a new variant called LB.1. The highly contagious omicron subvariant, along with the fast-growing ...

LB Pharmaceuticals aims to show that what is old can become new again with a lead drug candidate that’s a modified version of a decades-old schizophrenia medication from Sanofi. The strategy is ...

Many drugs are available for schizophrenia, but insufficient efficacy and intolerable side effects leave an unmet need that biotech companies are still trying to fill. LB Pharmaceuticals is not ...

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...

LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new chief commercial officers, according to a pair of announcements this week. New ...

There are no signs so far that the new LB.1 variant is causing more severe disease in COVID-19 patients, the Centers for Disease Control and Prevention says, as infections have begun to accelerate in ...

Headlines are again warning of a new COVID variant in Australia. This time it’s LB.1, or as some experts have dubbed it, “D-FLiRT”. Emerging evidence suggests LB.1 could be more transmissible than ...